Kanabo Group PLC Company Webinar
22 Febrero 2022 - 1:00AM
RNS Non-Regulatory
TIDMKNB
Kanabo Group PLC
22 February 2022
Kanabo Group Plc
("Kanabo" or the "Company")
Webinar and Q&A
Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis
Company focussing on the development and distribution of
cannabis-derived products for medical patients and wellness CBD
consumers, announces it will hold a company webinar via Vox Markets
on Wednesday 23 February 2022 at 5.30pm (GMT).
Following the announcement made yesterday of the acquisition of
the GP Service Limited (the "GP Service"), a UK-based private
primary care telemedicine provider, Avihu Tamie, CEO of Kanabo, and
Atul Devani, Executive Chairman and co-founder of the GP Service,
will host a webinar to discuss the strategic acquisition.
Highlights:
-- The GP Service is an approved provider on the NHS digital
framework for video and on-line consultations
-- The GP Service is able to able to electronically deliver
prescriptions to a network of 4,200 pharmacies including major high
street chains and independent pharmacies
-- The GP Service provides online GP video consultation services
to corporate clients as an occupational health service for
employers as well as pharmacies, including a major high street
pharmacy chain
-- Kanabo intends to develop The GP Service platform to become
one of Europe's first digitally led and legally compliant providers
for Kanabo's products and wellness CBD services following
regulatory approval
-- The acquisition will facilitate the rapid growth of the GP
Service existing digital and telemedicine business and will
establish a new and fully compliant channel to market for Kanabo's
products
This webinar is open to all, subject to registration. To
register and submit questions prior to the event, please use the
following link:
https://voxmarkets.brand.live/c/kanabo-webinar
Those who follow Kanabo Group plc on the Vox Markets platform
will automatically be invited.
For further information, please visit
http://www.kanabogroup.com/ or contact the following:
Kanabo Group Plc Via Vox Markets
Avihu Tamir, CEO
Peterhouse Capital Ltd (Financial Tel: +44 (0)20 7469 0930
Adviser)
Eran Zucker / Lauren Riley
Peterhouse Capital Ltd (Corporate Tel: +44 (0)20 7469 0930
Broker)
Lucy Williams / Charles Goodfellow / Duncan Vasey / Martin
Lampshire
Vox Markets (Investor Relations) KanaboGroup@voxmarkets.co.uk
Kat Perez kperez@voxmarkets.co.uk
About Kanabo Group Plc
Kanabo Group Plc is creating a new standard in the medical
cannabis industry to improve the well-being of millions of people
around the world by providing a better alternative to the smoking
of medicinal cannabis flowers. Kanabo, which was the first
medicinal cannabis company to IPO on London Stock Exchange, has a
focus on the distribution of cannabis-derived products for medical
patients and non-THC products for CBD consumers. It has conducted
extensive Research & Development to produce high-quality
cannabis extract formulas, innovative medical-grade vaporizers, and
various non-smoking consumption solutions. Kanabo sells a range of
medical cannabis products and wellness CBD products in the Primary
Markets, including its VapePod, which delivers a metered dose with
every inhalation.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUAARRUOUUUUR
(END) Dow Jones Newswires
February 22, 2022 02:00 ET (07:00 GMT)
Kanabo (LSE:KNB)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Kanabo (LSE:KNB)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024